HTLV-1 associated myelopathy in Canada.

HTLV-1 associated myelopathy in Canada.

We report the clinical and laboratory findings of six Canadian patients with progressive myelopathy associated with HTLV-1 infection. The diagnosis was suspected on clinical grounds and supported by serological studies and positive gene amplification. Only five had emigrated from an area endemic for...

Bibliográfalaš dieđut
Váldodahkkit:	Power, C, Weinshenker, BG, Dekaban, G, Ebers, G, Francis, G, Rice, G
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	1989

Geahča maid

ABSENCE OF ANTIBODIES TO HTLV-I AND HTLV-III IN SERA OF PATIENTS WITH MS AND CHRONIC MYELOPATHY
Dahkki: Rice, G, et al.
Almmustuhtton: (1986)

Absence of antibody to HTLV I and III in sera of Canadian patients with multiple sclerosis and chronic myelopathy.
Dahkki: Rice, G, et al.
Almmustuhtton: (1986)

Plasma proteome analysis in HTLV-1-associated myelopathy/tropical spastic paraparesis.
Dahkki: Kirk, P, et al.
Almmustuhtton: (2011)

HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy.
Dahkki: Jeffery, K, et al.
Almmustuhtton: (1999)

Some clinical and pathologic observations on chronic myelopathy: a variant of multiple sclerosis.
Dahkki: Weinshenker, BG, et al.
Almmustuhtton: (1990)

HAND WASTING IN CERVICAL SPONDYLITIC MYELOPATHY
Dahkki: Goodridge, A, et al.
Almmustuhtton: (1984)

Clinical, histological and immunological features of HTLV-1-associated infective dermatitis
Dahkki: Hlela, C, et al.
Almmustuhtton: (2010)

Devastating aquaporin-4 and HTLV-1-associated necrotizing encephalopathy.
Dahkki: Symmonds, M, et al.
Almmustuhtton: (2012)

Devastating aquaporin-4 and HTLV-1-associated necrotizing encephalopathy
Dahkki: Symmonds, M, et al.
Almmustuhtton: (2012)

Sjogren's myelopathy
Dahkki: Mukhtyar, C, et al.
Almmustuhtton: (2005)

A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis.
Dahkki: Weinshenker, BG, et al.
Almmustuhtton: (1992)

Autoimmune disease and HTLV-1 infection.
Dahkki: Bowness, P, et al.
Almmustuhtton: (1991)

Human T-lymphotropic virus type 1(HTLV-1) associated infective dermatitis
Dahkki: Hlela, C
Almmustuhtton: (2011)

Sjogren's syndrome-associated myelopathy: response to immunosuppressive treatment.
Dahkki: Vincent, T, et al.
Almmustuhtton: (2003)

Remission of psoriatic lesions with muromonab-CD3 (orthoclone OKT3) treatment.
Dahkki: Weinshenker, BG, et al.
Almmustuhtton: (1989)

Systemic interferon alfa in multiple sclerosis.
Dahkki: Weinshenker, BG, et al.
Almmustuhtton: (1989)

The natural history of multiple sclerosis.
Dahkki: Weinshenker, BG, et al.
Almmustuhtton: (1987)

Clonality of HTLV-2 in natural infection
Dahkki: Melamed, A, et al.
Almmustuhtton: (2014)

An open trial of OKT3 in patients with multiple sclerosis.
Dahkki: Weinshenker, BG, et al.
Almmustuhtton: (1991)

Is Sjogren myelopathy Devic disease?
Dahkki: Sofat, N, et al.
Almmustuhtton: (2008)

Transverse myelopathy and radiculomyelopathy associated with pulmonary atypical Mycobacterium infections.
Dahkki: White, V, et al.
Almmustuhtton: (2001)

The interaction between HTLV-1 Tax protein and the proteasome
Dahkki: Hemelaar, J, et al.
Almmustuhtton: (2001)

Cervical myelopathy caused by an exostosis of the posterior arch of C1
Dahkki: Chooi, Yew Siong, et al.
Almmustuhtton: (2005)

HTLV-1 and HIV infections of the central nervous system in tropical areas.
Dahkki: Cabre, P, et al.
Almmustuhtton: (2000)

Glucose metabolism and oxygen availability govern reactivation from latency of the human retrovirus HTLV-1
Dahkki: Kulkarni, A, et al.
Almmustuhtton: (2017)

HTLV-1 and HIV-2 infection are associated with increased mortality in a rural West African community.
Dahkki: van Tienen, C, et al.
Almmustuhtton: (2011)

The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome.
Dahkki: Weinshenker, BG, et al.
Almmustuhtton: (1991)

The natural history of multiple sclerosis: a geographically based study. 4. Applications to planning and interpretation of clinical therapeutic trials.
Dahkki: Weinshenker, BG, et al.
Almmustuhtton: (1991)

HTLV-1 in rural Guinea-Bissau: prevalence, incidence and a continued association with HIV between 1990 and 2007.
Dahkki: van Tienen, C, et al.
Almmustuhtton: (2010)

Tuberculous myelopathy associated with longitudinally extensive lesion: a clinicoradiological review of reported cases
Dahkki: Md Noh, Mohamad Syafeeq Faeez, et al.
Almmustuhtton: (2020)

A PRELIMINARY CLINICAL-TRIAL OF ORTHOCLONE OKT-STAR-3 TREATMENT IN CHRONICALLY PROGRESSIVE MULTIPLE-SCLEROSIS
Dahkki: Weinshenker, B, et al.
Almmustuhtton: (1988)

Myelopathy and reactive microgliosis and astrogliosis in equine back pain
Dahkki: Musa Mayaki, Abubakar, et al.
Almmustuhtton: (2020)

Myelopathy in primary Sjogren's syndrome: diagnostic and therapeutic aspects.
Dahkki: Hermisson, M, et al.
Almmustuhtton: (2002)

Candidate polyanionic microbicides inhibit HTLV-1 infection, fusion, and receptor interactions
Dahkki: Romer, D, et al.
Almmustuhtton: (2007)

In vitro evidence consistent with an interaction between wild‐type and mutant SOD1 protein associated with canine degenerative myelopathy
Dahkki: Qi, Yao, et al.
Almmustuhtton: (2019)

Epidemiology of multiple sclerosis in London and Middlesex County, Ontario, Canada.
Dahkki: Hader, W, et al.
Almmustuhtton: (1988)

The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability.
Dahkki: Weinshenker, BG, et al.
Almmustuhtton: (1989)

The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course.
Dahkki: Weinshenker, BG, et al.
Almmustuhtton: (1989)

Expanding the DARS phenotype: late-adult onset myelopathy and leukoencephalopathy
Dahkki: Tan, Ai Huey, et al.
Almmustuhtton: (2023)

Cervical radiculopathy and cervical myelopathy: diagnosis and management in primary care
Dahkki: McCartney, S, et al.
Almmustuhtton: (2017)